医学课件慢性肾功能衰竭张玖强_第1页
医学课件慢性肾功能衰竭张玖强_第2页
医学课件慢性肾功能衰竭张玖强_第3页
医学课件慢性肾功能衰竭张玖强_第4页
医学课件慢性肾功能衰竭张玖强_第5页
已阅读5页,还剩19页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

慢性肾功能衰竭 Chronic Renal Failure 整理:张玖强 Phase of Chronic Kidney Failure GRFGRF (Ccr ml/min)(Ccr ml/min) CrCr( (mol/L)mol/L) Early Early PhasePhase 50205020 Normal 2035%Normal 2035% 186442186442 Failure Failure PhasePhase 20102010 Normal 1020%Normal 1020% 450770450770 End PhaseEnd Phase770770 Etiological Factors Primary Chronic Glomerunephritis(6070%) Obstructive nephropathy Diabetic nephropathy Lupus nephritis Hypertension nephropathy Polycystic Kidney Nephron damage Glomerulosc lerosis Uremia Pathogenesis Mechanism of CRF deteriorating n Health survive nephron - trade-off hypothesis n Glomerulus Hyperfiltration Hypothesis Pathogenesis Mechanism of CRF deteriorating n Renal tubule Hypermetabolism hypothesis Reneal tubule lesion 、Interstitial inflammation and fibrosis。 n Other Angiotensin II、Transforming growth factor, ECM Lipid metabolism disorder, LDL, Protein filter 增生硬化性肾小球肾炎,代偿肥大增生硬化性肾小球肾炎,代偿肥大(H) (H) 与萎缩与萎缩(A)(A)区域相间存在区域相间存在 ( HE, 40 )( HE, 40 ) Pathogenesis Occurrence Mechanism of Various kinds in Uremia Kidney Principal Function Maintenance wate ,electrolure,acid-base equilibration; Eliminating metabolism refuse; Endocrine function: Erythropoietin, 1-hydroxylase; Degradation pheromone:Insulin and so on; PathogenesisPathogenesis Occurrence Mechanism of Occurrence Mechanism of Various kinds in UremiaVarious kinds in Uremia 1. 1. Water-Electrolyte and Acid-base Water-Electrolyte and Acid-base dysequilidrium;dysequilidrium; 2. 2. Metabolism refuse retentionMetabolism refuse retention,Endocrine Endocrine hormones savings, causing uremia symptom.hormones savings, causing uremia symptom. Clinical situation n Sodium dysequilibrium Desiccation Edema Low sodium(Dilution) High sodium n K dysequilibrium Water-Electrolyte and Acid-base Water-Electrolyte and Acid-base dysequilibriumdysequilibrium n Acidosis:Common death cause n Calcium and Phosphorus dysequilibrium Low Calcium:1,25(OH)2D3 High Phosphorus: n Hypermagnesemia Clinical situationClinical situation Water-Electrolyte and Acid-base Water-Electrolyte and Acid-base dysequilibriumdysequilibrium n Cardia-blood vessel systemic symptoms Hypertension Cardia-insufficiency Pericarditis Atherosclerosis n Respiratory systemic symptoms Respiratory profound Uremic pneumonia Pleurisy Clinical situationClinical situation Each systemic symptomsEach systemic symptoms n Blood systemic manifestation Anemia :EPO ,RBC destruction and so on Hemorrhagic tendency Leucocyte abnormilly n Nervus-Muscular systemic manifestation Muscle spasm Coma Peripheral nervous lesion Clinical situationClinical situation Each systemic symptomsEach systemic symptoms n Gastrointestinal manifestation Appetite descent Nausea and Vomiting Gastrointestinal hemorrhage n Skin manifestation Uremia Facial Features Skin to tickle Clinical situationClinical situation Each systemic symptomsEach systemic symptoms n Renal Osteodystrophy Clinical Manifestation 10% X-ray 40% Bone biopsy 90% Osteitis fibrosa (纤维性骨炎) Renal Osteomalacia (肾性骨软化症) Osteoporosis (骨质疏松) Renal Osteosclerosis (肾性骨硬化症) Clinical situationClinical situation Each systemic symptomsEach systemic symptoms n Endocrine disturbance Plasm1,25(OH)2D3 , Renin , PTH, Estrin (雌激素) Testosterone (睾丸素) n Easy combine infection Common infection in Lung and Urinary tract n Metabolism disturbance Hypothermia (体温过低), Carbohydrate Metabolism disturbance Sugar Tolerance decrease, Hyperuricemia, Lipo-Metabolism Disorder Clinical situationClinical situation Each systemic symptomsEach systemic symptoms Diagnosis n Diagnosis of Background Disease based Earlier Period:Imagelogy,Renal Biopsy Late Period:Difficult for diagnosis backgound disease n Finding Facts of deteriorating in CFR Deteriorate Facts: Hypovolemia;Infection ; Urinary tract obstruction; Congestive heart failure ; Severity arrhythmia; Blood pressure fluctuation Treatment I Therapeutics of background disease and deteriorate agent. Treatment II Slowing Development in CRF n Diet Treatment n Essential Amino Acid n Angiotensin-Converting Enzyme Inhibitor Angiotensin II receptor 1 antagonist Blood creatinine 350mol/L, Blood creatinine elevating over than 30% stop using 。 n Other Anti lipideomia Treatment III Complication Treatment nWater-Electrolyte imbalance nMetabolic Acidosis nCalcium-Phosphorum metabolism imbalance nCardia-bl

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论